FDA Investigator James D Bridges

James D Bridges has conducted inspections on 89 sites in 5 countries as of 20 Apr 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
89
Last Inspection Date:
20 Apr 2015
Investigator Role:
FDA Investigator
Redica ID:
100000757
Countries of Inspections:
United States of America, Germany, Italy, Canada, Austria
FDA Investigators that have inspected at least one site in common with James D Bridges:
Adetutu M Gidado, Alice S Tsao, Althea A Williams, Amal M Mansour, Amanda T Zick, Anastasia M Shields, Anita Narula, PhD, Anita R Michael, Ann B Okon, April L Young, Arduino Frankovic, Arsen Karapetyan, Arthur G Hurst, Azza Talaat, Barbara Janine Breithaupt, Bijoy Panicker, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brian J Ryan, Bruce G Cooper, Bruce H Mccullough, Carley R Anderson, Carolyn J Cook, Cassandra L Winters, Charanjeet Jassal, Charisse K Green, Cheryl L Manney, Christopher S Fields, Christopher T Peters, Crystal A Branch, Cynthia A Stempniak, Daniel L Aisen, David A Carlson, David A Laplante, David G Eng, David M Mcnew, David R Delucia, Diamond M Oden, Diane E Bruce, Diane L Raccasi, Dipesh K Shah, Douglas A Campbell, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth H Davis, Elizabeth H Slazak, Erika E Englund, PhD, Erin L Nagel, Evelyn Taha, Felix Maldonado, Francis A Guidry, George C Amedro, Gwyn G Dickinson, Harry J Brewer, Helen B Ricalde, Helen Verdel, Hilary K Wagner, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James I Giefer, Jay B Shah, Jay T Wong, Jazmine N Brown, Jeanette L Mcginnis, Joanne M Schlossin, Joel R Merriman, Johannes S Corley, John A Gonzalez, John A Podsadowski, John P Shelton, Johnna L Bleem, Jose A Lopez, Jose Acruz Gonzalez, Jose Ohernandez Guzman, Joseph A Famiglietti, Joseph J Vannelli, Joseph Milcetic, Joshua D Lopez, Joy P Matthias, Joyce A Williams, Juan Rjimenez Garcia, Judy Keihl, Julie D Bringger, Julie Scoma, Junho Pak, Kalavati Suvarna, PhD, Karen A Morgante, Karen L Kosar, Kathryn A Nagy, Kellia N Hicks, Kenneth G Klobus, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kim M Downing, Kimberley A Gordon, Kimberley A Ricketts, Kimberly Y Smithson, Kyle J Spencer, Laura Fontan, MS, Lauren E Blaser, Lawrence J Stringer, LCDR Chad N Thompson, Linda M Pyjas, Linda M Sacco, Manhar R Patel, Marc S Neubauer, Marcellinus D Dordunoo, Margaret M Annes, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Mark D Johnson, Marlene L Davis, Mary M Finn, Matthew D Schnittker, Michael A Charles, Michael Shanks, MS, Michael W Burd, Mindy M Chou, Morris Paul, Mra Mcculloughj, Mra Munizn, Nancy A Saxenian Emmons, Nancy M Espinal, Nayan J Patel, Parul M Patel, Patricia A Clark, Patrick C Klotzbuecher, Patrick L Wisor, Patsy J Domingo, Paul A Bonneau, Paul Mouris, Rachael A Moliver, Rajiv R Srivastava, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard K Glabach, Robert C Coleman, Robert C Steyert, Rose Ashley, Russ E Davis, Salvatore N Randazzo, Sangeeta M Khurana, PhD, Santos E Camara, Sasha M Latonis, Shannon A Dinardo, Simone E Pitts, Sony Mathews, Stephen D Eich, Steven D Kehoe, Steven J Libal, Susan M Jackson, Susan T Hadman, Syeda N Mahazabin, Tammy S Notto, Thomas L Bellonte, Thomas P Hansen, Tonia F Bernard, Unnee Ranjan, Wayne E Seifert, Wendy G Tan, PhD, Wendy M Stone, William C Lubas, William J Leonard, William P Chilton, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yuyan Liang, Zachary A Bogorad

James D Bridges's Documents

Publish Date Document Type Title
April, 2015 FDA 483 Sandoz GmbH - Form 483, 2015-04-30
October, 2014 EIR Fresenius Kabi USA, LLC - EIR, 2014-10-24
May, 2012 FDA 483 CooperVision Inc. - Form 483, 2012-05-29
September, 2009 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2009-09-17
July, 2011 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2011-07-08
September, 2012 EIR Lundbeck Pharmaceuticals Italy SpA - EIR, 2012-09-28
June, 2011 FDA 483 Safetec of America Inc. - Form 483, 2011-06-21
October, 2011 FDA 483 ONY Biotech Inc. - Form 483, 2011-10-06
May, 2010 FDA 483 Lornamead - Form 483, 2010-05-07
September, 2009 FDA 483 Abraxis BioScience - Form 483, 2009-09-17
March, 2015 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2015-03-06
March, 2014 FDA 483 CooperSurgical, Inc. - Form 483, 2014-03-21
May, 2011 FDA 483 Arkema Inc. - Form 483, 2011-05-23
January, 2013 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2013-01-11
October, 2014 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2014-10-24
June, 2013 EIR CooperSurgical, Inc. - EIR, 2013-06-28
March, 2015 EIR Fresenius Kabi USA, LLC - EIR, 2015-03-06
January, 2010 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2010-01-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more